Finch Therapeutics Group Inc (FNCH)
2.485
-0.60
(-19.45%)
USD |
NASDAQ |
Apr 17, 16:00
2.46
-0.02
(-1.01%)
After-Hours: 20:00
Finch Therapeutics Group Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.1531 |
| September 30, 2022 | 0.1211 |
| June 30, 2022 | 0.0919 |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0076 |
| December 31, 2020 | -0.0189 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0189
Minimum
Dec 2020
0.1531
Maximum
Dec 2022
0.0355
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 55.37M |
| Total Liabilities (Quarterly) | 32.49M |
| Shareholders Equity (Quarterly) | 22.89M |